These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8922201)

  • 1. Rapid discontinuation of hypnotics in terminal cancer patients: a prospective study.
    Bruera E; Fainsinger RL; Schoeller T; Ripamonti C
    Ann Oncol; 1996 Oct; 7(8):855-6. PubMed ID: 8922201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2020 Jun; 15(2):147-154. PubMed ID: 32386690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
    Belleville G; Morin CM
    Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety or depression during withdrawal of hypnotic treatments.
    Lader M
    J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pregabalin in patients with hypnotic-dependent insomnia.
    Cho YW; Song ML
    J Clin Sleep Med; 2014 May; 10(5):545-50. PubMed ID: 24812540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insomnia due to hypnotic abuse].
    Poluektov MG; Pchelina PV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):24-29. PubMed ID: 28300810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound insomnia and hypnotic self administration.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia.
    Urru SA; Pasina L; Minghetti P; Giua C
    Int J Clin Pharm; 2015 Dec; 37(6):1004-8. PubMed ID: 26198541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Situation and problem of administration methods and the intermission of hypnotics.
    Uchimura N; Takeuchi N; Kuwahara H; Nose I; Hashizume Y; Shirakawa S; Ohyama T; Maeda H
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):295-6. PubMed ID: 12047602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnotics. Their place in therapeutics.
    Nicholson AN
    Drugs; 1986 Feb; 31(2):164-76. PubMed ID: 2868877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxation to assist sleep medication withdrawal.
    Lichstein KL; Peterson BA; Riedel BW; Means MK; Epperson MT; Aguillard RN
    Behav Modif; 1999 Jul; 23(3):379-402. PubMed ID: 10467890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound insomnia and newer hypnotics.
    Lader M
    Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose determinants of rebound insomnia.
    Roehrs TA; Zorick FJ; Wittig RM; Roth T
    Br J Clin Pharmacol; 1986 Aug; 22(2):143-7. PubMed ID: 3530302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benefits and risks of hypnotics].
    Benoit O
    Neurophysiol Clin; 1991 Oct; 21(4):245-65. PubMed ID: 1795692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
    Kales A; Kales JD
    J Clin Psychopharmacol; 1983 Apr; 3(2):140-50. PubMed ID: 6132933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study.
    Garzón C; Guerrero JM; Aramburu O; Guzmán T
    Aging Clin Exp Res; 2009 Feb; 21(1):38-42. PubMed ID: 19225268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sleep disorders and hypnotic agents: medical, social and economical impact].
    Touitou Y
    Ann Pharm Fr; 2007 Jul; 65(4):230-8. PubMed ID: 17652991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.